# Pulse Biosciences, Inc.: filings

PLSE · Nasdaq · CIK 1625101 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/plse.md) · [Financials](/companies/plse/financials.md) · [Filings](/companies/plse/filings.md) · [Insiders](/companies/plse/insiders.md)

## Reports and events: 257 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 196, 8-K 171, 10-Q 32, 3 27, CORRESP 27, UPLOAD 22, SC 13D/A 17, EFFECT 13, S-8 13, DEF 14A 12, S-3 11, 10-K 10, S-3/A 10, SD 7, 144 6, 424B5 6, 4/A 5, D 4, DEFA14A 4, SC 13G 4, 10-K/A 3, 424B3 3, 424B4 3, FWP 3, PRE 14A 3, S-1/A 3, SC 13G/A 3, 10-Q/A 2, 3/A 2, 8-K/A 2, SC 13D 2, SCHEDULE 13D/A 2, 424B2 1, 5 1, 8-A12B 1, 8-K12B 1, CERTNAS 1, CT ORDER 1, NT 10-Q 1, POS AM 1, S-1 1, S-3MEF 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 12:43 ET | [8-K](/filings/0001437749-26-032601.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032601 |
| 2026-10-07 | 13:06 ET | [8-K](/filings/0001437749-26-032271.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032271 |
| 2026-09-15 | 20:44 ET | [8-K](/filings/0001437749-26-030456.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-030456 |
| 2026-09-15 | 12:54 ET | [8-K](/filings/0001437749-26-030392.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-030392 |
| 2026-08-06 | 21:04 ET | [8-K](/filings/0001437749-26-026351.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-026351 |
| 2026-08-06 | 20:23 ET | [10-Q](/filings/0001437749-26-026288.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026288 |
| 2026-08-06 | 20:06 ET | [8-K](/filings/0001437749-26-026256.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026256 |
| 2026-07-29 | 13:01 ET | [8-K](/filings/0001437749-26-024758.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-024758 |
| 2026-06-12 | 20:05 ET | [8-K](/filings/0001437749-26-020464.md) | 5.07 Shareholder vote results | 0001437749-26-020464 |
| 2026-06-10 | 12:55 ET | [8-K](/filings/0001437749-26-020085.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-020085 |
| 2026-05-14 | 13:02 ET | [10-Q](/filings/0001437749-26-016897.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016897 |
| 2026-05-13 | 22:36 ET | [SCHEDULE 13D/A](/filings/0001193125-26-222151.md) | Ownership report, active investor, amended | 0001193125-26-222151 |
| 2026-05-11 | 13:17 ET | [DEF 14A](/filings/0001437749-26-016006.md) | Proxy statement, period 2026-06-11 | 0001437749-26-016006 |
| 2026-05-06 | 13:05 ET | [8-K](/filings/0001437749-26-015039.md) | 8.01 Other events | 0001437749-26-015039 |
| 2026-05-04 | 13:16 ET | [8-K](/filings/0001437749-26-014547.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-014547 |
| 2026-04-30 | 20:11 ET | [10-K/A](/filings/0001437749-26-014203.md) | Annual report, amended, period 2025-12-31 | 0001437749-26-014203 |
| 2026-04-27 | 13:18 ET | [8-K](/filings/0001437749-26-013383.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-013383 |
| 2026-04-16 | 13:00 ET | [8-K](/filings/0001437749-26-012498.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-012498 |
| 2026-04-09 | 13:16 ET | [8-K](/filings/0001437749-26-011831.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-011831 |
| 2026-04-07 | 12:59 ET | [8-K](/filings/0001437749-26-011546.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-011546 |
| 2026-03-27 | 20:32 ET | [8-K](/filings/0001437749-26-010105.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-010105 |
| 2026-03-17 | 12:59 ET | [8-K](/filings/0001437749-26-008511.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-008511 |
| 2026-03-12 | 13:20 ET | [8-K](/filings/0001437749-26-007839.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-007839 |
| 2026-03-09 | 13:31 ET | [8-K](/filings/0001437749-26-007283.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-007283 |
| 2026-03-03 | 21:34 ET | [8-K](/filings/0001437749-26-006629.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-006629 |
| 2026-03-02 | 14:21 ET | [8-K/A](/filings/0001437749-26-006269.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-006269 |
| 2026-02-27 | 22:26 ET | [8-K](/filings/0001437749-26-006141.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-006141 |
| 2026-02-19 | 21:28 ET | [8-K](/filings/0001437749-26-004739.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-004739 |
| 2026-02-19 | 21:09 ET | [8-K](/filings/0001437749-26-004726.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-004726 |
| 2026-02-19 | 21:08 ET | [10-K](/filings/0001437749-26-004724.md) | Annual report, period 2025-12-31 | 0001437749-26-004724 |
| 2026-02-06 | 00:15 ET | [8-K](/filings/0001437749-26-003256.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-003256 |
| 2026-01-14 | 14:00 ET | [8-K](/filings/0001437749-26-001225.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-001225 |
| 2026-01-09 | 14:11 ET | [8-K](/filings/0001437749-26-000938.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-000938 |
| 2025-12-18 | 14:00 ET | [8-K](/filings/0001437749-25-038213.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-038213 |
| 2025-12-12 | 21:04 ET | [8-K](/filings/0001437749-25-037727.md) | 5.07 Shareholder vote results | 0001437749-25-037727 |
| 2025-12-09 | 21:04 ET | [8-K](/filings/0001437749-25-037255.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-037255 |
| 2025-11-13 | 14:28 ET | [8-K](/filings/0001437749-25-034658.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-034658 |
| 2025-11-05 | 21:16 ET | [10-Q](/filings/0001437749-25-033354.md) | Quarterly report, period 2025-09-30 | 0001437749-25-033354 |
| 2025-11-05 | 21:11 ET | [8-K](/filings/0001437749-25-033348.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-033348 |
| 2025-10-28 | 14:19 ET | [DEF 14A](/filings/0001437749-25-031837.md) | Proxy statement, period 2025-12-09 | 0001437749-25-031837 |
| 2025-10-24 | 12:54 ET | [8-K](/filings/0001437749-25-031680.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-031680 |
| 2025-10-10 | 13:02 ET | [8-K](/filings/0001437749-25-030816.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-030816 |
| 2025-10-01 | 20:06 ET | [8-K](/filings/0001437749-25-030184.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001437749-25-030184 |
| 2025-09-08 | 20:05 ET | [8-K](/filings/0001437749-25-028560.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-028560 |
| 2025-09-03 | 22:09 ET | [DEF 14A](/filings/0001437749-25-028189.md) | Proxy statement, period 2025-09-30 | 0001437749-25-028189 |
| 2025-09-02 | 13:03 ET | [8-K](/filings/0001437749-25-028093.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-028093 |
| 2025-08-26 | 13:03 ET | [8-K](/filings/0001437749-25-027725.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-027725 |
| 2025-08-12 | 20:17 ET | [10-Q](/filings/0001437749-25-026209.md) | Quarterly report, period 2025-06-30 | 0001437749-25-026209 |
| 2025-08-12 | 20:10 ET | [8-K](/filings/0001437749-25-026195.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-026195 |
| 2025-07-14 | 20:46 ET | [8-K](/filings/0001437749-25-022675.md) | 5.02 Departure or appointment of officers or directors | 0001437749-25-022675 |

Page 1 of 6. [Older](/companies/plse/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.